Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer. - Wikidata - wikimedia - TriplyDB

Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

http://www.wikidata.org/entity/Q33477106

about

Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy.Osteopontin: a potentially important therapeutic target in cancer.The GM-CSF receptor family: mechanism of activation and implications for disease.Multifunctional ECM proteins in bone and teeth.

P2860

Q35142045-7F3CDE09-D726-457B-A563-EEF65B93F907 Q35768332-38C4F87F-B86C-407F-BE41-169D612F85E9 Q35881808-04438AE2-984D-406F-AC1E-88C15BD4A0E6 Q36104744-CAF0522C-18F2-43B4-9DB3-16B46B9C03F9 Q36928308-84FBC7C6-53A7-4B7A-A22C-BC78EC817153 Q37896087-EC0486A7-03CD-4B28-A58A-B54E56C6EA60 Q37976887-D2C0E10A-5D1E-43DB-8E10-4DB2128DFE24 Q38184229-E92A41F8-FC2B-4EFB-BB25-4253A61F08CE

P2860

Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer.

http://www.wikidata.org/entity/Q33477106

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification of osteopontin- ...... model of human breast cancer.

@ast

Identification of osteopontin- ...... model of human breast cancer.

@en

type

label

Identification of osteopontin- ...... model of human breast cancer.

@ast

Identification of osteopontin- ...... model of human breast cancer.

@en

prefLabel

Identification of osteopontin- ...... model of human breast cancer.

@ast

Identification of osteopontin- ...... model of human breast cancer.

@en

P1433

Q33477106-FC577A0F-D2D4-46DB-BBE7-02D9E1C6BC2A

P1476

Q33477106-AEFC008D-FC64-45A3-9DA1-E95EEB7EE3C1

P2093

Q33477106-0B35C6B4-E4F7-44AC-8288-48CC344BAB11

Q33477106-A185F952-5F44-44F5-BA31-FDA8875437A4

Q33477106-D515BA12-BE3E-4A03-8BFF-47B7783A0625

P2860

Q33477106-0F62FF00-E756-46DD-B8CC-34942081AFAF

Q33477106-1007DA3C-C252-4E9B-901B-44753A5CFC64

Q33477106-33802046-64B1-4976-A217-A33072C5A940

Q33477106-47D7D21B-4396-401D-8E44-72BFC6553EF5

Q33477106-4A6BB571-51A4-4A41-9160-867EF8B35AB7

Q33477106-4EACF5AE-3180-4687-8367-343E551158C6

Q33477106-55ABE6F1-3EC0-4053-8EDF-967B6C0AE6A6

Q33477106-71F7757D-75EE-41A6-AFD3-7C2135EA975B

Q33477106-720A585D-44EA-4165-8FB6-2497339C223D

Q33477106-77386F3C-6C1D-435E-8A35-67ED1E556033

P2888

Q33477106-94280D2C-F726-4376-9376-7301BF55EA84

P304

Q33477106-03674243-5186-4B3B-A37E-5C7A36E3A354

P31

Q33477106-F95E0767-B61A-4059-A2AA-F2BCA301A7A3

P356

Q33477106-94EFF908-D9C7-491A-BA0C-E66A116222AE

P478

Q33477106-F8FF1530-771A-4FA2-91D2-D6EE63B1C535

P577

Q33477106-31FEFED0-8151-4647-A064-A0E94EE90BB3

P5875

Q33477106-771935BE-63C2-4B4D-B877-620D175CD4A2

P6179

Q33477106-EF1F85FD-E7EA-4A90-8E0A-DF4503276E6F

P698

Q33477106-C1D263C0-A056-4837-99E3-4D4A8F998215

P932

Q33477106-BA3F89B5-FC8F-4951-8EDC-D62AA99F4DAD

P356

1756-0500-2-119

P1433

BMC Research Notes

P1476

Identification of osteopontin- ...... model of human breast cancer.

@en

P2093

Hongtao Guo

http://www.w3.org/2001/XMLSchema#string

Paul C Kuo

http://www.w3.org/2001/XMLSchema#string

Zhiyong Mi

http://www.w3.org/2001/XMLSchema#string

P2860

TIS7 regulation of the beta-catenin/Tcf-4 target gene osteopontin (OPN) is histone deacetylase-dependent

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

RNA aptamer blockade of osteopontin inhibits growth and metastasis of MDA-MB231 breast cancer cells.

Vascular endothelial growth factor and osteopontin in tumor biology.

Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

The metastasis gene osteopontin: a candidate target for cancer therapy.

Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer

Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model.

Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.

P2888

1756-0500-2-119

P304

119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-2-119

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26333863

http://www.w3.org/2001/XMLSchema#string

P6179

1041707637

http://www.w3.org/2001/XMLSchema#string

P698

19570203

http://www.w3.org/2001/XMLSchema#string

P932

2713255

http://www.w3.org/2001/XMLSchema#string